Top Markets
Coin of the day
SQZ Biotechnologies Company SQZ Biotechnologies Company

SQZ Biotechnologies Company

SQZ
Kedudukan dalam Saham #38920
SQZ Biotechnologies, a biotechnology firm currently in the clinical development... SQZ Biotechnologies, a biotechnology firm currently in the clinical development phase, is focused on creating cell-based therapies for various severe ailments, including cancerous growths, autoimmune disorders, and infectious diseases. Its primary experimental therapeutic, known as SQZ-PBMC-HPV, is derived from its SQZ Antigen Presenting Cells technology. This treatment is currently undergoing Phase I clinical trials, both as a standalone therapy and alongside other immune-oncology treatments, to address advanced or metastatic solid tumors positive for HPV16, encompassing cancers of the cervix, head-and-neck, anus, penis, vulva, and vagina. Furthermore, the company is progressing with SQZ-AAC-HPV, another Phase I clinical candidate targeting the same HPV16+ advanced or metastatic solid tumors, which is also being evaluated as a single agent and in conjunction with other immune-modulating agents. Beyond these, SQZ Biotechnologies is also advancing its SQZ Activating Antigen Carriers and SQZ Tolerizing Antigen Carriers platforms. Established in 2013, the company operates from its main office in Watertown, Massachusetts.
Harga Saham
$0.05083
Disegerakkan terakhir: 2023-09-01
Modal Pasaran
$732.57K
Perubahan (1 hari)
8.15%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan SQZ Biotechnologies Company (SQZ)

Kategori

Sejarah harga saham bagi SQZ Biotechnologies Company (SQZ)
Harga penutupan tertinggi: $0.05 pada 2023-09-01

Harga penutupan terendah: $13.25 pada 2020-10-01
Sejarah harga saham SQZ Biotechnologies Company dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2023 -94.93%
2022 -90.40%
2021 -61.01%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$506.54 29.78%
US
$843.80 29.33%
NL
$729.87 6.86%
CH
$1.07K -6.40%
KR
$252.41 11.51%
BE